|
Roche Molecular Diagnostics offers a range of technology platforms designed to improve the workflow efficiencies and test results integrity for labs performing PCR and real-time PCR testing.
After successfully automating PCR for diagnostic and research applications, RMD continued innovating this technology through development of real-time PCR. Now considered the state-of-the-art standard for molecular diagnostics, real-time PCR greatly improves the sensitivity, specificity and accuracy of earlier-generation PCR tests.
Using a closed-tube format, real-time PCR, together with AmpErase Enzyme reduces the risk of cross-contamination between samples. With its wide dynamic range, a single real-time PCR assay can detect and accurately quantify as little as a few virus particles up to millions, enabling important clinical advancements, such as the highly accurate viral load testing critical to proper assessment of disease progression and response to therapy for HIV and hepatitis.
ROCHE, COBAS, AMPLILINK, AMPLIPREP, AMPERASE, AMPLICOR, LIGHTCYCLER and TAQMAN are trademarks of Roche.
The technology used for the LightCycler® System is licensed from Idaho Technology, Inc.
|
